Testosterone overprescribed, particularly for older men

(Medical Xpress) -- Testosterone prescriptions have surged since 2006 due to promotional activity, according to University of Sydney research which also found growing overuse in older men.

The research by Professor David Handelsman from the University and director of the ANZAC Research Institute, Concord Hospital has been published today in the .

It follows another recent study, led by Professor Handelsman and published in the journal of Clinical Endocrinology, which suggests testosterone decline in is not a result of ageing but of medical conditions and ill health that accumulate as men get older.

"This Healthy Man Study looked at very healthy men aged 40 and over and found that a decrease in testosterone was not associated with increasing age. Instead factors such as obesity or a history of smoking were strongly linked with any decrease," Professor Handelsman said.

The study supported the interpretation that diseases associated with ageing and not ageing itself affects in older men. It underlines the inappropriateness of the increasing sales of testosterone to older men which is highlighted in Professor Handelsman's MJA article.

The study in the MJA analyses data from the Pharmaceutical Benefits Scheme and IMS, a company that provides national sales data year by year.

"I found that stable market growth over 15 years was disrupted by sharp increases following the introduction of two new testosterone products - a gel and a long-acting injectable version by a single company which became a monopoly supplier," Professor Handelsman said.

"There is growing overuse of testosterone in older men as an anti-ageing tonic and non-specific treatment for , for which sound evidence is lacking. Yet at the same time genuine low-testosterone conditions due to diseases of the reproductive system remain underdiagnosed."

At present new uses of testosterone should be restricted to carefully designed clinical trials to determine whether there is any objective benefit from treatment for conditions such as obesity, diabetes or cardiovascular diseases that accumulate as men age, Professor Handelsman observed.

"The progressive increase appears to be due to promotion-driven marketing of products which do not comply with the Pharmaceutical Benefits Scheme prescribing criteria and suggest that more effective implementation of those criteria is needed."

add to favorites email to friend print save as pdf

Related Stories

Study of testosterone in older men

Nov 12, 2009

Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center announced today that it will participate in a large national study of the effectiveness of testosterone as a treatment for anemia, cardiovascular disease, ...

Recommended for you

Breakthrough in understanding of important blood protein

56 minutes ago

The human body contains a unique protein that has the unusual property of destroying itself after a few hours of existence - it must therefore be continually recreated and is no stable protein. The protein, ...

Key to aging immune system is discovered

1 hour ago

There's a good reason people over 60 are not donor candidates for bone marrow transplantation. The immune system ages and weakens with time, making the elderly prone to life-threatening infection and other ...

Putting a number on pain

2 hours ago

"How much pain are you in?" It's a harder question than many people think. Tools for assessing patients' pain—be they children or adults—rely on perception: a subjective measure that eludes quantification ...

New infections cause dormant viruses to reactivate

2 hours ago

The famous slogan is "A diamond is forever," but that phrase might be better suited to herpes: Unlike most viruses, which succumb to the immune system's attack, herpes remains in the body forever, lying in wait, sometimes ...

User comments